Artificial Intelligence and Gestacional Diabetes
Enrolling by invitation · Not applicable
Conditions studied: Gestational Diabetes, Macrosomia, Fetal
In brief
Artificial intelligence (AI) technology can assist medical teams in remote monitoring and continuing education of women with gestational diabetes (GDM), potentially improving adherence to interventions and impacting outcomes. An AI remote monitoring model called "monitoring model for women with GDM using pharmacological therapy," created by the ChamouDr technical team, will be analyzed focusing on disease education, glycemic control monitoring, and therapeutic interventions. Women diagnosed with GDM are invited to participate in the study and sign a free and informed consent form. The AI tool is installed on the pregnant woman's cell phone, who receives instructions to collect capillary blood glucose 6 times a day according to the protocol, at home, and report the results via WhatsApp to the study tool. Algorithm generated by the AI model based on self monitoring of blood glucose (SMBG) informs about diabetes control in the last week. The dashboard is accessible via a web browser, and signals: in green and red for patients with satisfactory and unsatisfactory control, respectively. Thus, the AI model optimizes the team's time in analyzing and treating patients appropriately in a simple, cost-effective, and accessible way.
Key facts
- Study ID
- NCT07345143
- Run by
- JOSE FERNANDO VILELA-MARTIN
- People needed
- 100
- Starts
- 2024-06-01
- Expected to finish
- 2027-12-20
- Last updated by the study team
- 2026-01-15
Who can join
Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Gestacional diabetes women with gestational age of up to 28 weeks and 6 days
- Gestacional diabetes women who sign the free and informed consent form
You may not qualify if…
- Gestational age greater than 28 completed weeks at the first consultation
- Participants with overt DM (fasting glucose > 126 mg/dl or postprandial > 200 mg/dl)
- Unknown outcome.
Where it is running
- Fundação Faculdade Regional de Medicina de São José do Rio Preto — São José do Rio Preto, São Paulo, Brazil
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.